> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Tempus AI's Lefkofsky Plans To Sell 250,000 Shares After Four Accounts Sold 850,000
- URL: https://www.bullished.co/tempus-ais-lefkofsky-plans-to-sell-250-000-shares-after-four-accounts-sold-850-000-c4ad9a73/
- Published: 2026-10-27T20:59:31.000Z
- Updated: 2026-10-27T20:59:31.000Z
- Description: The $16.8 million proposed sale follows 13 sales across four related accounts that brought in $55,814,261 over three months.
- Author: Matteo Parrino
- Tags: Insider Trades, TEM, Industry: Technology

[Tempus AI](https://www.bullished.co/tag/tem/) CEO and Chairman Eric Lefkofsky plans to sell [250,000 Class A shares](https://www.sec.gov/Archives/edgar/data/0001114357/000196858226001077/xsl144X01/primary%5Fdoc.xml?ref=bullished.co) with a stated market value of $16.8 million, according to a Form 144 — the notice insiders file before selling — dated Tuesday. The form lists J.P. Morgan Securities as broker and an approximate sale date of October 27.

## Four accounts, 850,000 shares already sold

The same form lists 13 sales over the past three months totaling 850,000 shares and $55,814,261 in gross proceeds. The sellers were four separate accounts, not all of them Lefkofsky's own:

- Blue Media, LLC sold 540,000 shares in four sales for $36,255,022.
- Gray Media, LLC sold 230,000 shares in four sales for $15,441,954.
- Vas.org Foundation sold 50,000 shares in one sale for $2,103,118.
- Lefkofsky Family Foundation sold 30,000 shares in four sales for $2,014,168.

Blue Media, Gray Media and the Lefkofsky Family Foundation each sold on July 28, August 25, September 17 and September 22\. Vas.org sold once, on July 28.

## Who is selling, and what Tempus does

Tempus AI is a healthcare technology company that runs labs and builds software to personalize diagnostic tests, mainly in cancer, by linking results to a patient's clinical data. According to its latest annual report, its database held more than 8.6 million de-identified patient records as of December 31, 2025.

The form describes Lefkofsky as an officer, director and holder of more than 10% of the shares. It traces the shares to four acquisition lots, some bought directly from the company for cash.

A planned sale on a Form 144 is a notice of intent; a later SEC filing would show whether the 250,000 shares were sold and at what price.

### Sources

- [Form 144 — Eric P Lefkofsky (TEM)](https://www.sec.gov/Archives/edgar/data/0001114357/000196858226001077/xsl144X01/primary%5Fdoc.xml?ref=bullished.co) — SEC EDGAR

### More on Tempus AI

- [Tempus AI Lines Up $192.5 Million In Cash From Bristol-Myers Squibb And Pathos Data Deals](https://www.bullished.co/tempus-ai-lines-up-192-5-million-in-cash-from-bristol-myers-squibb-and-pathos-data-deals-d878e78a/)
- [Personalis Holders Vote November 30 On Tempus Deal; Tempus Stock At $64.34 Versus $52.47 Pre-Announcement](https://www.bullished.co/personalis-holders-vote-november-30-on-tempus-deal-tempus-stock-at-64-34-versus-52-47-pre-c5d2b95e/)

[All Tempus AI (TEM) coverage →](https://www.bullished.co/tag/tem/)